AB Science will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET

Core Viewpoint - AB Science will host a live webcast on January 28, 2025, to provide updates on its masitinib platform [1][2] Company Overview - AB Science is a pharmaceutical company founded in 2001, focusing on the research, development, and commercialization of protein kinase inhibitors (PKIs) [1][2] - The company targets diseases with high unmet medical needs, including oncology, neurological diseases, inflammatory diseases, and viral diseases [2] Product Development - The lead compound, masitinib, is already registered for veterinary medicine and is being developed for human medicine [2] - The company emphasizes its commitment to addressing diseases that are often lethal or refractory to previous treatments [2]